Application of omics data in regulatory toxicology: report of an international BfR expert workshop

Archives of Toxicology

Volumn 89, Issue 11, 2015, Pages 2177-2184

  Marx Stoelting, P ^a   Braeuning, A ^a   Buhrke, T ^a   Lampen, A ^a   Niemann, L ^a   Oelgeschlaeger, M ^a   Rieke, S ^a   Schmidt, F ^a   Heise, T ^a   Pfeil, R ^a   Solecki, R ^a  

^a FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLASSIFICATION; GERMANY; HUMAN; INTERNATIONAL RELATIONS; MEDICAL EXPERT; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; TOXICOLOGY; WORKSHOP; ANIMAL; ANIMAL TESTING ALTERNATIVE; LEGISLATION AND JURISPRUDENCE; PROCEDURES; REPRODUCIBILITY; TOXICITY TESTING;

ANIMAL TESTING ALTERNATIVES; ANIMALS; HUMANS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; TOXICITY TESTS; TOXICOLOGY;

EID: 84947616820     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-015-1602-x     Document Type: Article

References (21)

1. Boobis AR, Doe JE, Heinrich-Hirsch B et al (2008) IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit Rev Toxicol 38(2):87–96. doi:10.1080/10408440701749421
2. Chervitz SA, Deutsch EW, Field D et al (2011) Data standards for Omics data: the basis of data sharing and reuse. Methods Mol Biol 719:31–69. doi:10.1007/978-1-61779-027-0_2
3. ECETOC (2013) Omics and risk assessment science. In: ECETOC (ed) Workshop report No 25, Brussels. ISSN-2078-7200-25
4. ECHA (2011) Guidance on information requirements and chemical safety assessment Part B: hazard assessment Version 2.1, accessible at https://www.echa.europa.eu/documents/10162/13643/information_requirements_part_b_en.pdf. Accessed Sept 2015
5. EFSA (2011) Statistical significance and biological relevance. EFSA 9(9):2372
6. EFSA (2014) Modern methodologies and tools for human hazard assessment of chemicals. EFSA 12(4):3638
7. EMEA (2007) Note for guidance on definitions for genomic biomarkers, pharmacogenomics, pharmacogenetics, genomic data and sample coding categories. EMEA. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002880.pdf. Accessed Sept 2015
8. Fuscoe JC, Tong W, Shi L (2007) QA/QC issues to aid regulatory acceptance of microarray gene expression data. Environ Mol Mutagen 48(5):349–353. doi:10.1002/em.20293
9. Hartung T (2009) Toxicology for the twenty-first century. Nature 460(7252):208–212. doi:10.1038/460208a
10. Hartung T, Hoffmann S, Stephens M (2013) Mechanistic validation. ALTEX 30(2):119–130
11. Jennen D, Ruiz-Aracama A, Magkoufopoulou C et al (2011) Integrating transcriptomics and metabonomics to unravel modes-of-action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in HepG2 cells. BMC Syst Biol 5:139. doi:10.1186/1752-0509-5-139
12. OECD (2013) Guidance document on developing and assessing adverse outcome pathways OECD environment. Health and Safety Publications, Paris
13. Paules RS (2006) Toxicogenomics and environmental diseases: the search for biomarkers predictive of adverse effects. Med Lav 97(2):322–323
14. Robinson JF, Pennings JL, Piersma AH (2012) A review of toxicogenomic approaches in developmental toxicology. Methods Mol Biol 889:347–371. doi:10.1007/978-1-61779-867-2_22
15. Shi L, Reid LH, Jones WD et al (2006) The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24(9):1151–1161. doi:10.1038/nbt1239
16. Stahl S, Ittrich C, Marx-Stoelting P et al (2005) Genotype–phenotype relationships in hepatocellular tumors from mice and man. Hepatology 42(2):353–361. doi:10.1002/hep.20768
17. Tarazona JV (2013) Use of new scientific developments in regulatory risk assessments: challenges and opportunities. Integr Environ Assess Manag 9(3):e85–e91. doi:10.1002/ieam.1445
18. Tinwell H, Friry-Santini C, Rouquie D et al (2007) Evaluation of the antiandrogenic effects of flutamide, DDE, and linuron in the weanling rat assay using organ weight, histopathological, and proteomic approaches. Toxicol Sci 100(1):54–65. doi:10.1093/toxsci/kfm208
19. Tralau T, Oelgeschlager M, Gurtler R et al (2015) Regulatory toxicology in the twenty-first century: challenges, perspectives and possible solutions. Arch Toxicol 89(6):823–850. doi:10.1007/s00204-015-1510-0
20. van Ravenzwaay B, Brunborg G, Kleinjans J, Galay BM, Vrijhof H (2012) Use of ‘omics to elucidate mechanism of action and integration of ‘omics in a systems biology concept. Mutat Res 746(2):95–96. doi:10.1016/j.mrgentox.2012.04.004
21. WHO/IPCS (2004) IPCS risk assessment terminology (Part 1). http://www.inchem.org/documents/harmproj/harmproj/harmproj1.pdf. Accessed Sept 2015